Updated on 21 October 2026
Fundación MEDINA –Natural product-based drug discovery expertise for novel small molecule antivirals
Project Manager at FUNDACIÓN MEDINA
Granada, Spain
About
Fundación MEDINA (Spain) is seeking to join a consortium preparing a proposal for HORIZON-HLTH-2027-01-DISEASE-05.
MEDINA offers expertise in natural product-based drug discovery, microbial screening, bioactive compound identification, analytical chemistry and metabolomics, contributing to the discovery, characterisation and optimisation of small molecule antiviral candidates.
We are looking for consortium coordinators and partners specialising in virology, antiviral screening, medicinal chemistry, preclinical development and clinical research to advance novel antiviral therapeutics against the epidemic-prone viruses targeted by the call.
Topic
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
MedChem partner proposal on HORIZON-HLTH-2027-01-DISEASE-05 call
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Cyril B. DOUSSON
CEO at Ai-biopharma
Montpellier, France
Project cooperation
RNA structure and viral genomics partner for antiviral discovery
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Michael Wolfinger
Founder & Principal Scientist, RNA Forecast e.U. at RNA Forecast e.U.
Vienna, Austria
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Irene Pérez López
Project manager _ Pre-award at Fundación Pública Miguel Servet - Navarrabiomed
Pamplona, Spain